We provide you with 20 years of free, institutional-grade data for HSTO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HSTO. Explore the full financial landscape of HSTO stock.
| Reported Date | CIK | Ticker | Type |
|---|
Histogen Inc(NASDAQ:HSTO) 
Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopeci...
Website: https://www.conatuspharma.com/
Founded: 2005
Full Time Employees: 22
CEO: Steven Mento
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about HSTO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.